Drug permeation enhancement via buccal route: possibilities and limitations

This publication has 23 references indexed in Scilit:

• GLP-1 Tablet in Type 2 Diabetes in Fasting and Postprandial Conditions
  Diabetes Care, 1997
• Continuous Flow Mucosal Cells for Measuring the in-Vitro Permeability of Small Tissue Samples
  Journal of Pharmaceutical Sciences, 1997
• Oramucosal Delivery of LHRH: Pharmacokinetic Studies of Controlled and Enhanced Transmucosal Permeation
  Pharmaceutical Development and Technology, 1996
• In Vivo Buccal Delivery of the Peptide Drug Buserelin with Glycodeoxycholate as an Absorption Enhancer in Pigs
  Pharmaceutical Research, 1996
• The Transmucosal Absorption of Recombinant Human Interferon-α B/D Hybrid in the Rat and Rabbit
  Journal of Pharmacy and Pharmacology, 1995
• An in vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers: apparent evidence of effective enhancement without tissue damage
  International Journal of Pharmaceutics, 1994
• Buccal delivery for peptide drugs
  Journal of Controlled Release, 1992
• Existence of a specialized absorption mechanism for cefadroxil, an aminocephalosporin antibiotic, in the human oral cavity
  International Journal of Pharmaceutics, 1992
• Effect of bile salts on the rectal absorption of sodium ampicillin in rats.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
• New mucosal dosage form of insulin.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1981